These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25941590)

  • 1. Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors.
    Devaud C; Westwood JA; Teng MW; John LB; Yong CS; Duong CP; Smyth MJ; Darcy PK; Kershaw MH
    Oncoimmunology; 2014 Nov; 3(11):e963395. PubMed ID: 25941590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated CTLA-4-independent immunosuppression of Treg cells disturbs CTLA-4 blockade-mediated antitumor immunity.
    Watanabe T; Ishino T; Ueda Y; Nagasaki J; Sadahira T; Dansako H; Araki M; Togashi Y
    Cancer Sci; 2023 May; 114(5):1859-1870. PubMed ID: 36762794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice.
    Christiaansen AF; Boggiatto PM; Varga SM
    J Immunol Methods; 2014 Apr; 406():58-65. PubMed ID: 24642426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between tumors can affect responses to therapy.
    Devaud C; John LB; Westwood JA; Yong CS; Beavis PA; Schwendener RA; Darcy PK; Kershaw MH
    Oncoimmunology; 2015 Jul; 4(7):e975572. PubMed ID: 26140251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
    Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
    J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade.
    Vackova J; Polakova I; Johari SD; Smahel M
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33923750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient Treg depletion enhances therapeutic anti-cancer vaccination.
    Fisher SA; Aston WJ; Chee J; Khong A; Cleaver AL; Solin JN; Ma S; Lesterhuis WJ; Dick I; Holt RA; Creaney J; Boon L; Robinson B; Lake RA
    Immun Inflamm Dis; 2017 Mar; 5(1):16-28. PubMed ID: 28250921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human CD8
    Machicote A; Belén S; Baz P; Billordo LA; Fainboim L
    Front Immunol; 2018; 9():2788. PubMed ID: 30555473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of Foxp3+ regulatory T cells increases severity of mechanical allodynia and significantly alters systemic cytokine levels following peripheral nerve injury.
    Lees JG; Duffy SS; Perera CJ; Moalem-Taylor G
    Cytokine; 2015 Feb; 71(2):207-14. PubMed ID: 25461400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.
    Suffner J; Hochweller K; Kühnle MC; Li X; Kroczek RA; Garbi N; Hämmerling GJ
    J Immunol; 2010 Feb; 184(4):1810-20. PubMed ID: 20083650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
    Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T
    Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
    Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
    J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro effect of pembrolizumab on different T regulatory cell subsets.
    Toor SM; Syed Khaja AS; Alkurd I; Elkord E
    Clin Exp Immunol; 2018 Feb; 191(2):189-197. PubMed ID: 28963773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth.
    Teng MW; Ngiow SF; von Scheidt B; McLaughlin N; Sparwasser T; Smyth MJ
    Cancer Res; 2010 Oct; 70(20):7800-9. PubMed ID: 20924111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages of Foxp3(+) regulatory T cell depletion using DEREG mice.
    Mayer CT; Lahl K; Milanez-Almeida P; Watts D; Dittmer U; Fyhrquist N; Huehn J; Kopf M; Kretschmer K; Rouse B; Sparwasser T
    Immun Inflamm Dis; 2014 Nov; 2(3):162-5. PubMed ID: 25505550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion.
    Teng MW; Swann JB; von Scheidt B; Sharkey J; Zerafa N; McLaughlin N; Yamaguchi T; Sakaguchi S; Darcy PK; Smyth MJ
    Cancer Res; 2010 Apr; 70(7):2665-74. PubMed ID: 20332236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl gallate exhibits potent antitumor activities by inhibiting tumor infiltration of CD4+CD25+ regulatory T cells.
    Lee H; Lee H; Kwon Y; Lee JH; Kim J; Shin MK; Kim SH; Bae H
    J Immunol; 2010 Dec; 185(11):6698-705. PubMed ID: 21048105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody.
    Ha D; Tanaka A; Kibayashi T; Tanemura A; Sugiyama D; Wing JB; Lim EL; Teng KWW; Adeegbe D; Newell EW; Katayama I; Nishikawa H; Sakaguchi S
    Proc Natl Acad Sci U S A; 2019 Jan; 116(2):609-618. PubMed ID: 30587582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical roles of regulatory B and T cells in helminth parasite-induced protection against allergic airway inflammation.
    Gao X; Ren X; Wang Q; Yang Z; Li Y; Su Z; Li J
    Clin Exp Immunol; 2019 Dec; 198(3):390-402. PubMed ID: 31397879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.